HomeCARA • NASDAQ
add
Cara Therapeutics Inc
Previous close
$0.66
Day range
$0.65 - $0.71
Year range
$0.50 - $4.45
Market cap
38.72M USD
Avg Volume
307.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 2.14M | -65.37% |
Operating expense | 6.82M | -5.00% |
Net income | -30.70M | -15.12% |
Net profit margin | -1.44K | -232.41% |
Earnings per share | -0.56 | -14.29% |
EBITDA | -27.22M | 1.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 69.77M | -38.95% |
Total assets | 90.10M | -41.22% |
Total liabilities | 60.30M | 261.53% |
Total equity | 29.80M | — |
Shares outstanding | 54.68M | — |
Price to book | 1.21 | — |
Return on assets | -63.13% | — |
Return on capital | -99.43% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -30.70M | -15.12% |
Cash from operations | -30.45M | 12.03% |
Cash from investing | 25.95M | 46.55% |
Cash from financing | -685.00K | -222.32% |
Net change in cash | -5.19M | 68.28% |
Free cash flow | -22.50M | 10.20% |
About
Founded
2004
Headquarters
Website
Employees
55